EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN

PURPOSE: To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) in Japanese patients with diabetic macular edema (DME). METHODS: VIVID-DME was a Phase 3 study comprising patients with DME randomized 1:1:1 to IAI 2 mg every 4 weeks (2q4), IAI 2 mg every 4 weeks until Week 16...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retina
Main Authors: Terasaki, Hiroko, Shiraki, Kunihiko, Ohji, Masahito, Metzig, Carola, Schmelter, Thomas, Zeitz, Oliver, Sowade, Olaf, Kobayashi, Masato, Vitti, Robert, Berliner, Alyson, Shiraga, Fumio
Formato: Artigo
Idioma:Inglês
Publicado em: Retina 2019
Assuntos:
Original Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510325/
https://ncbi.nlm.nih.gov/pubmed/29470308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000002100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados